A Phase 3 Study of Nasal Glucagon (LY900018) Compared to Intramuscular Glucagon for Treatment of Insulin-induced Hypoglycemia in Japanese Patients With Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 21 Sep 2018
At a glance
- Drugs Glucagon (Primary) ; Glucagon (Primary)
- Indications Hypoglycaemia
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 12 Sep 2018 Status changed from active, no longer recruiting to completed.
- 03 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 27 Jul 2018 Planned End Date changed from 31 Aug 2018 to 18 Aug 2018.